Showing results (181-190 of 689) with videos related to

Sort By:
Pageof 69
Expert Review of Gastroenterology & Hepatology|April 9, 2009
Pathophysiology and management of gastroparesisJoan Khoo, Christopher K Rayner, Karen L Jones, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|September 15, 2009
Insulin secretion in healthy subjects and patients with Type 2 diabetes--role of the gastrointestinal tractJing Ma, Christopher K Rayner, Karen L Jones, et al.
Diabetes Care|March 12, 2017
Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist DulaglutideMichael A Nauck, Jean-Louis Frossard, Jamie S Barkin, et al.
Regulatory Peptides|April 11, 2003
The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP)Juris J Meier, Baptist Gallwitz, Nina Siepmann, et al.
Diabetes|November 25, 2004
Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjectsJuris J Meier, Baptist Gallwitz, Bartholomaeus Kask, et al.
Diabetes Care|August 6, 2011
Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trialMichael A Nauck, Stefano Del Prato, Juris J Meier, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2011
Inhibition of DPP-4 with vildagliptin improved insulin secretion in response to oral as well as "isoglycemic" intravenous glucose without numerically changing the incretin effect in patients with type 2 diabetesIrfan Vardarli, Michael A Nauck, Lars D Köthe, et al.
World Journal of Gastroenterology|April 13, 2006
Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controlsJuris J Meier, Michael A Nauck, Bartholomaeus Kask, et al.
The American Journal of Gastroenterology|February 20, 2003
Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15,000 Australian adultsJohann Hammer, Stuart Howell, Peter Bytzer, et al.
Critical Care (London, England)|March 8, 2014
Incretins and the intensivist: what are they and what does an intensivist need to know about them?Mark P Plummer, Marianne J Chapman, Michael Horowitz, et al.
Pageof 69